← FDA Drug Approvals (Drugs@FDA)

ANDA221061

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SYNTHON BV · Approved 2026-10-02

Drug application

FDA Application #

ANDA221061

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

SYNTHON BV

First approval

2026-10-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown